NO174959C - Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivaterInfo
- Publication number
- NO174959C NO174959C NO883122A NO883122A NO174959C NO 174959 C NO174959 C NO 174959C NO 883122 A NO883122 A NO 883122A NO 883122 A NO883122 A NO 883122A NO 174959 C NO174959 C NO 174959C
- Authority
- NO
- Norway
- Prior art keywords
- aminobutyl
- phenyl
- therapeutically active
- analogous process
- arylamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8710026A FR2618149B1 (fr) | 1987-07-16 | 1987-07-16 | Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique |
Publications (4)
Publication Number | Publication Date |
---|---|
NO883122D0 NO883122D0 (no) | 1988-07-13 |
NO883122L NO883122L (no) | 1989-01-17 |
NO174959B NO174959B (no) | 1994-05-02 |
NO174959C true NO174959C (no) | 1994-08-10 |
Family
ID=9353186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO883122A NO174959C (no) | 1987-07-16 | 1988-07-13 | Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater |
Country Status (21)
Country | Link |
---|---|
US (2) | US5001159A (da) |
EP (1) | EP0300865B1 (da) |
JP (1) | JPH0794417B2 (da) |
KR (1) | KR890001957A (da) |
AR (1) | AR247380A1 (da) |
AT (1) | ATE73762T1 (da) |
AU (1) | AU600376B2 (da) |
CA (1) | CA1306748C (da) |
CS (1) | CS405391A3 (da) |
DE (1) | DE3869257D1 (da) |
DK (1) | DK397388A (da) |
ES (1) | ES2037257T3 (da) |
FI (1) | FI883377A (da) |
FR (1) | FR2618149B1 (da) |
GR (1) | GR3004458T3 (da) |
HU (1) | HU198903B (da) |
IE (1) | IE61843B1 (da) |
IL (1) | IL87089A (da) |
NO (1) | NO174959C (da) |
NZ (1) | NZ225430A (da) |
ZA (1) | ZA885150B (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116851A (en) * | 1990-01-26 | 1992-05-26 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides |
FR2694557B1 (fr) * | 1992-08-05 | 1994-09-23 | Synthelabo | Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique. |
JPH09501405A (ja) * | 1993-05-27 | 1997-02-10 | スミスクライン・ビーチャム・ラボラトワール・ファルマソーティク | 抗不整脈用n−置換3−ベンズアゼピンまたはイソキノリン |
FR2705675B1 (fr) * | 1993-05-27 | 1996-05-03 | Smithkline Beecham Labo Pharma | Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments. |
FR2706895A1 (en) * | 1993-06-22 | 1994-12-30 | Synthelabo | Tetrahydroisoquinoline derivatives, their preparation and their application in therapeutics |
FR2706894A1 (en) * | 1993-06-22 | 1994-12-30 | Synthelabo | N-Phenyl-N-(piperidinoalkyl)arylamide derivatives, their preparation and their application in therapeutics |
FR2715654B1 (fr) * | 1994-02-03 | 1996-03-22 | Synthelabo | Dérivé de N-[3-(1,2,3,4-tétrahydroisoquinoléin-2-yl)-propyl]-N-phényl-5,6,7,8-tétrahydronaphtalène-2-carboxamide, leur préparation et leur application en thérapeutique. |
TW281667B (da) * | 1994-02-03 | 1996-07-21 | Synthelabo | |
FR2715652B1 (fr) * | 1994-02-03 | 1996-03-22 | Synthelabo | Dérivés de N-[3-[(2,3-dihydro-1H-inden-2-yl)alkyl-amino]propyl]-N-phényl-5,6,7,8-tétrahydronaphtalène-2-carboxamide leur préparation et leur application en thérapeutique. |
WO1995024390A1 (en) * | 1994-03-11 | 1995-09-14 | Smithkline Beecham Plc | Novel phenyl(-alkyl/alkoxy)-1-aminoalkyl-substituted piperidines and pyrrolidines as calcium channel antagonists |
WO1996027595A1 (en) * | 1995-03-08 | 1996-09-12 | Smithkline Beecham Laboratoires Pharmaceutiques | Heterocyclycarboxamides and other compounds for the treatment of the cardiac arrhythmias |
GB9708694D0 (en) * | 1997-04-30 | 1997-06-18 | Smithkline Beecham Plc | Compounds |
GB9708805D0 (en) * | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
JP2002527433A (ja) | 1998-10-08 | 2002-08-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ドーパミンd3受容体のモジュレーター(抗精神病薬)として有用なテトラヒドロベンズアゼピン誘導体 |
DE60006954T2 (de) | 1999-05-10 | 2004-10-21 | Warner Lambert Co | Aromatische amide |
US7955170B2 (en) * | 2004-07-30 | 2011-06-07 | Igt | Providing non-bingo outcomes for a bingo game |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1232787A (da) * | 1967-08-08 | 1971-05-19 | ||
FR8120M (da) * | 1968-12-26 | 1970-08-03 | ||
US4808624A (en) * | 1984-06-28 | 1989-02-28 | Bristol-Myers Company | Pharmacologically active substituted benzamides |
-
1987
- 1987-07-16 FR FR8710026A patent/FR2618149B1/fr not_active Expired
-
1988
- 1988-06-15 AR AR88311432A patent/AR247380A1/es active
- 1988-07-05 EP EP88401741A patent/EP0300865B1/fr not_active Expired - Lifetime
- 1988-07-05 AT AT88401741T patent/ATE73762T1/de not_active IP Right Cessation
- 1988-07-05 DE DE8888401741T patent/DE3869257D1/de not_active Expired - Fee Related
- 1988-07-05 ES ES198888401741T patent/ES2037257T3/es not_active Expired - Lifetime
- 1988-07-12 IL IL87089A patent/IL87089A/xx not_active IP Right Cessation
- 1988-07-13 NO NO883122A patent/NO174959C/no unknown
- 1988-07-15 JP JP63177962A patent/JPH0794417B2/ja not_active Expired - Lifetime
- 1988-07-15 IE IE217988A patent/IE61843B1/en not_active IP Right Cessation
- 1988-07-15 DK DK397388A patent/DK397388A/da not_active Application Discontinuation
- 1988-07-15 NZ NZ225430A patent/NZ225430A/en unknown
- 1988-07-15 KR KR1019880008807A patent/KR890001957A/ko not_active Application Discontinuation
- 1988-07-15 ZA ZA885150A patent/ZA885150B/xx unknown
- 1988-07-15 FI FI883377A patent/FI883377A/fi not_active Application Discontinuation
- 1988-07-15 HU HU883698A patent/HU198903B/hu not_active IP Right Cessation
- 1988-07-15 AU AU19077/88A patent/AU600376B2/en not_active Ceased
- 1988-07-15 CA CA000572175A patent/CA1306748C/en not_active Expired - Fee Related
-
1990
- 1990-05-02 US US07/517,419 patent/US5001159A/en not_active Expired - Fee Related
- 1990-06-19 US US07/540,229 patent/US5075325A/en not_active Expired - Fee Related
-
1991
- 1991-12-23 CS CS914053A patent/CS405391A3/cs unknown
-
1992
- 1992-04-29 GR GR920400824T patent/GR3004458T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AR247380A1 (es) | 1994-12-29 |
JPH0794417B2 (ja) | 1995-10-11 |
US5001159A (en) | 1991-03-19 |
NZ225430A (en) | 1990-01-29 |
DK397388A (da) | 1989-02-09 |
IE61843B1 (en) | 1994-11-30 |
AU600376B2 (en) | 1990-08-09 |
GR3004458T3 (da) | 1993-03-31 |
NO883122L (no) | 1989-01-17 |
NO174959B (no) | 1994-05-02 |
FR2618149A1 (fr) | 1989-01-20 |
FI883377A (fi) | 1989-01-17 |
FR2618149B1 (fr) | 1989-09-22 |
FI883377A0 (fi) | 1988-07-15 |
US5075325A (en) | 1991-12-24 |
JPS6434950A (en) | 1989-02-06 |
CA1306748C (en) | 1992-08-25 |
KR890001957A (ko) | 1989-04-06 |
IE882179L (en) | 1989-01-16 |
IL87089A0 (en) | 1988-12-30 |
ZA885150B (en) | 1989-03-29 |
EP0300865B1 (fr) | 1992-03-18 |
ATE73762T1 (de) | 1992-04-15 |
DE3869257D1 (de) | 1992-04-23 |
NO883122D0 (no) | 1988-07-13 |
EP0300865A1 (fr) | 1989-01-25 |
IL87089A (en) | 1993-02-21 |
HU198903B (en) | 1989-12-28 |
DK397388D0 (da) | 1988-07-15 |
CS405391A3 (en) | 1992-09-16 |
ES2037257T3 (es) | 1993-06-16 |
AU1907788A (en) | 1989-01-19 |
HUT47079A (en) | 1989-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
NO175371C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyrederivater | |
FI96861C (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
NO174959C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater | |
FI96601C (fi) | Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi | |
NO176713C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater | |
NO175429C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater | |
NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
NO178967C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater | |
NO176142C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoalkoksyfenylderivater | |
FI93444B (fi) | Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi | |
NO173784C (no) | Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater | |
NO176477C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater | |
NO176100C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater | |
NO175781C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser | |
NO174200C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser | |
FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
NO173332C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive tetrahydrofuranderivater | |
NO176105C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater | |
NO174668C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater | |
NO176242C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater | |
FI92188C (fi) | Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi | |
NO179367C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive fenoksy-heterocykliske forbindelser | |
NO174887C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aryl- alkyl-pyrrol-2-carboxylsyreforbindelser |